All In MedTech

FDA Clearance Tracker · P190018-S046

Clareon Vivity™ Toric Extended Vision UV Absorbing Hydrophobic Intraocular Lens (IOL)

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: May 15, 2026 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

May 15, 2026

Approved

Time to decision

186 days

Received Nov 10, 2025. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P190018-S046
Device name
Clareon Vivity™ Toric Extended Vision UV Absorbing Hydrophobic Intraocular Lens (IOL)
Applicant location
Fort Worth, TX
Received
Nov 10, 2025
Decided
May 15, 2026
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P190018

Device type

Device class
Class III
Regulation
21 CFR 886.3600
Specialty
Ophthalmology

Every decision under product code HQL

FDA's approval statement

As written in FDA's record.

approval for expanding the range for Clareon Vivity™ Toric Extended Vision UV Absorbing Hydrophobic IOLs in the lens case configuration to include 4.50 D (CNWET7/CCWET7), 5.25 D (CNWET8/CCWET8), and 6.0 D (CNWET9/CCWET9) cylindrical power models.

Source documents

Other decisions for Alcon Laboratories, LLC

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.